CA2990289A1 - Procedes et systemes pour communications rf dans des procedures d'extraction de sang - Google Patents
Procedes et systemes pour communications rf dans des procedures d'extraction de sang Download PDFInfo
- Publication number
- CA2990289A1 CA2990289A1 CA2990289A CA2990289A CA2990289A1 CA 2990289 A1 CA2990289 A1 CA 2990289A1 CA 2990289 A CA2990289 A CA 2990289A CA 2990289 A CA2990289 A CA 2990289A CA 2990289 A1 CA2990289 A1 CA 2990289A1
- Authority
- CA
- Canada
- Prior art keywords
- blood
- memory
- rfid tag
- data
- network node
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000605 extraction Methods 0.000 title claims abstract description 170
- 238000000034 method Methods 0.000 title claims description 371
- 238000004891 communication Methods 0.000 title description 190
- 238000003860 storage Methods 0.000 claims abstract description 178
- 230000015654 memory Effects 0.000 claims description 865
- 238000013500 data storage Methods 0.000 claims description 36
- 238000004422 calculation algorithm Methods 0.000 claims description 29
- 230000001976 improved effect Effects 0.000 abstract description 17
- 239000000047 product Substances 0.000 description 212
- 238000012545 processing Methods 0.000 description 144
- 238000007726 management method Methods 0.000 description 139
- 239000000758 substrate Substances 0.000 description 114
- 235000013305 food Nutrition 0.000 description 109
- 230000006870 function Effects 0.000 description 106
- 230000008569 process Effects 0.000 description 98
- 238000012423 maintenance Methods 0.000 description 88
- 230000001965 increasing effect Effects 0.000 description 81
- 238000004519 manufacturing process Methods 0.000 description 69
- 239000002184 metal Substances 0.000 description 59
- 229910052751 metal Inorganic materials 0.000 description 59
- 239000000976 ink Substances 0.000 description 54
- 230000005540 biological transmission Effects 0.000 description 52
- 238000009826 distribution Methods 0.000 description 47
- 230000008439 repair process Effects 0.000 description 43
- 239000002131 composite material Substances 0.000 description 41
- 230000036541 health Effects 0.000 description 36
- 230000008859 change Effects 0.000 description 35
- 238000012544 monitoring process Methods 0.000 description 33
- 230000007613 environmental effect Effects 0.000 description 32
- 239000000463 material Substances 0.000 description 32
- 230000008901 benefit Effects 0.000 description 31
- 239000004020 conductor Substances 0.000 description 28
- 230000033001 locomotion Effects 0.000 description 28
- 238000012360 testing method Methods 0.000 description 28
- 238000005516 engineering process Methods 0.000 description 26
- 210000004369 blood Anatomy 0.000 description 24
- 239000008280 blood Substances 0.000 description 24
- 230000032258 transport Effects 0.000 description 24
- 239000000243 solution Substances 0.000 description 23
- 230000005855 radiation Effects 0.000 description 22
- 239000000825 pharmaceutical preparation Substances 0.000 description 21
- 229940127557 pharmaceutical product Drugs 0.000 description 21
- 230000004044 response Effects 0.000 description 19
- 238000007650 screen-printing Methods 0.000 description 19
- 238000012546 transfer Methods 0.000 description 19
- 239000007788 liquid Substances 0.000 description 18
- 238000012795 verification Methods 0.000 description 18
- 241000196324 Embryophyta Species 0.000 description 17
- 230000001413 cellular effect Effects 0.000 description 17
- 238000013461 design Methods 0.000 description 17
- 239000003814 drug Substances 0.000 description 17
- 238000001514 detection method Methods 0.000 description 16
- 238000003306 harvesting Methods 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 15
- 230000006378 damage Effects 0.000 description 15
- 239000007789 gas Substances 0.000 description 15
- 230000000670 limiting effect Effects 0.000 description 15
- 230000009471 action Effects 0.000 description 14
- 238000004458 analytical method Methods 0.000 description 14
- 238000000429 assembly Methods 0.000 description 14
- 239000012212 insulator Substances 0.000 description 14
- 230000002829 reductive effect Effects 0.000 description 14
- 229940079593 drug Drugs 0.000 description 13
- 238000007689 inspection Methods 0.000 description 13
- 230000001360 synchronised effect Effects 0.000 description 13
- 238000004220 aggregation Methods 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 238000007639 printing Methods 0.000 description 12
- 230000035939 shock Effects 0.000 description 12
- 238000011282 treatment Methods 0.000 description 12
- 230000002776 aggregation Effects 0.000 description 11
- 238000013507 mapping Methods 0.000 description 11
- 239000008267 milk Substances 0.000 description 11
- 210000004080 milk Anatomy 0.000 description 11
- 235000013336 milk Nutrition 0.000 description 11
- 230000035882 stress Effects 0.000 description 11
- 238000010586 diagram Methods 0.000 description 10
- 230000005055 memory storage Effects 0.000 description 10
- 238000007651 thermal printing Methods 0.000 description 10
- 238000004364 calculation method Methods 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 230000007547 defect Effects 0.000 description 9
- 230000005865 ionizing radiation Effects 0.000 description 9
- 238000004806 packaging method and process Methods 0.000 description 9
- 210000002381 plasma Anatomy 0.000 description 9
- 238000003908 quality control method Methods 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 230000001133 acceleration Effects 0.000 description 8
- 230000000875 corresponding effect Effects 0.000 description 8
- 230000008878 coupling Effects 0.000 description 8
- 238000010168 coupling process Methods 0.000 description 8
- 238000005859 coupling reaction Methods 0.000 description 8
- -1 parts Substances 0.000 description 8
- 230000001225 therapeutic effect Effects 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 239000003990 capacitor Substances 0.000 description 7
- 230000006855 networking Effects 0.000 description 7
- 230000008520 organization Effects 0.000 description 7
- 238000011084 recovery Methods 0.000 description 7
- 238000012384 transportation and delivery Methods 0.000 description 7
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
- 238000007906 compression Methods 0.000 description 6
- 230000006835 compression Effects 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- 239000011521 glass Substances 0.000 description 6
- 238000011068 loading method Methods 0.000 description 6
- 230000007774 longterm Effects 0.000 description 6
- 210000000056 organ Anatomy 0.000 description 6
- 239000003973 paint Substances 0.000 description 6
- 230000002688 persistence Effects 0.000 description 6
- 239000011347 resin Substances 0.000 description 6
- 229920005989 resin Polymers 0.000 description 6
- 239000007921 spray Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 239000003826 tablet Substances 0.000 description 6
- 230000007704 transition Effects 0.000 description 6
- 230000000712 assembly Effects 0.000 description 5
- 238000004590 computer program Methods 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 244000144972 livestock Species 0.000 description 5
- 239000003094 microcapsule Substances 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 238000001356 surgical procedure Methods 0.000 description 5
- 239000001993 wax Substances 0.000 description 5
- 206010002091 Anaesthesia Diseases 0.000 description 4
- 206010013710 Drug interaction Diseases 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 4
- 230000037005 anaesthesia Effects 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 230000002596 correlated effect Effects 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 239000000446 fuel Substances 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 230000010354 integration Effects 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 238000002483 medication Methods 0.000 description 4
- 150000002739 metals Chemical class 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 230000000474 nursing effect Effects 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 238000010422 painting Methods 0.000 description 4
- 230000000737 periodic effect Effects 0.000 description 4
- 238000002616 plasmapheresis Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 239000000779 smoke Substances 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 206010073306 Exposure to radiation Diseases 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 230000006399 behavior Effects 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000005684 electric field Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 230000002452 interceptive effect Effects 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 229910052755 nonmetal Inorganic materials 0.000 description 3
- 238000005457 optimization Methods 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 238000002271 resection Methods 0.000 description 3
- 238000012552 review Methods 0.000 description 3
- 238000005096 rolling process Methods 0.000 description 3
- 230000011218 segmentation Effects 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 230000003068 static effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 230000000153 supplemental effect Effects 0.000 description 3
- 230000008093 supporting effect Effects 0.000 description 3
- 230000008733 trauma Effects 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 229910000831 Steel Inorganic materials 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 230000003466 anti-cipated effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 238000001574 biopsy Methods 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 229940072645 coumadin Drugs 0.000 description 2
- 238000009223 counseling Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000000151 deposition Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- 238000010894 electron beam technology Methods 0.000 description 2
- 238000005530 etching Methods 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 238000009313 farming Methods 0.000 description 2
- 239000003337 fertilizer Substances 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 230000010006 flight Effects 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 210000003709 heart valve Anatomy 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 229940127554 medical product Drugs 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 238000003909 pattern recognition Methods 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- 238000000554 physical therapy Methods 0.000 description 2
- 230000004962 physiological condition Effects 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 230000010287 polarization Effects 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 238000012805 post-processing Methods 0.000 description 2
- 230000002028 premature Effects 0.000 description 2
- 230000000191 radiation effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000000246 remedial effect Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 238000004904 shortening Methods 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 239000010959 steel Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- PJVWKTKQMONHTI-UHFFFAOYSA-N warfarin Chemical compound OC=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 PJVWKTKQMONHTI-UHFFFAOYSA-N 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- ADHFMENDOUEJRK-UHFFFAOYSA-N 9-[(4-fluorophenyl)methyl]-n-hydroxypyrido[3,4-b]indole-3-carboxamide Chemical compound C1=NC(C(=O)NO)=CC(C2=CC=CC=C22)=C1N2CC1=CC=C(F)C=C1 ADHFMENDOUEJRK-UHFFFAOYSA-N 0.000 description 1
- 208000018084 Bone neoplasm Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- 241000272470 Circus Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 208000010496 Heart Arrest Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 208000036647 Medication errors Diseases 0.000 description 1
- 241001482237 Pica Species 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000002547 anomalous effect Effects 0.000 description 1
- 238000013473 artificial intelligence Methods 0.000 description 1
- 238000013474 audit trail Methods 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- JJWKPURADFRFRB-UHFFFAOYSA-N carbonyl sulfide Chemical compound O=C=S JJWKPURADFRFRB-UHFFFAOYSA-N 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 238000004883 computer application Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000000599 controlled substance Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000007728 cost analysis Methods 0.000 description 1
- 230000001808 coupling effect Effects 0.000 description 1
- 238000002788 crimping Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000013481 data capture Methods 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 238000013144 data compression Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000003989 dielectric material Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000004146 energy storage Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 238000005242 forging Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003574 free electron Substances 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 230000005251 gamma ray Effects 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- ZEKANFGSDXODPD-UHFFFAOYSA-N glyphosate-isopropylammonium Chemical compound CC(C)N.OC(=O)CNCP(O)(O)=O ZEKANFGSDXODPD-UHFFFAOYSA-N 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000009191 jumping Effects 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 238000012045 magnetic resonance elastography Methods 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 238000010339 medical test Methods 0.000 description 1
- 230000006386 memory function Effects 0.000 description 1
- 230000007595 memory recall Effects 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000005404 monopole Effects 0.000 description 1
- 239000002159 nanocrystal Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 230000010363 phase shift Effects 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 238000010094 polymer processing Methods 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 238000000275 quality assurance Methods 0.000 description 1
- 238000012372 quality testing Methods 0.000 description 1
- 230000005610 quantum mechanics Effects 0.000 description 1
- 230000005258 radioactive decay Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000013468 resource allocation Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000003938 response to stress Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 231100000279 safety data Toxicity 0.000 description 1
- 238000009781 safety test method Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 238000010187 selection method Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 238000005245 sintering Methods 0.000 description 1
- 238000005476 soldering Methods 0.000 description 1
- GOLXNESZZPUPJE-UHFFFAOYSA-N spiromesifen Chemical compound CC1=CC(C)=CC(C)=C1C(C(O1)=O)=C(OC(=O)CC(C)(C)C)C11CCCC1 GOLXNESZZPUPJE-UHFFFAOYSA-N 0.000 description 1
- 238000000528 statistical test Methods 0.000 description 1
- 238000012414 sterilization procedure Methods 0.000 description 1
- 238000013068 supply chain management Methods 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 239000003356 suture material Substances 0.000 description 1
- 230000007474 system interaction Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 239000002912 waste gas Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- FEACDYATMHKJPE-JXHOJRNMSA-N xxxx-3 Chemical compound C1CC(C)CC(OC)C(O)C(C)\C=C(C)\C(OC(N)=O)C(OC)CC\C=C(C)\C(=O)NC2=CC(O)=C(O)C1=C2 FEACDYATMHKJPE-JXHOJRNMSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
- G16H10/65—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records stored on portable record carriers, e.g. on smartcards, RFID tags or CD
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
Abstract
Dans des modes de réalisation de la présente invention, des capacités améliorées sont décrites pour une installation d'extraction de sang disposant d'un interrogateur RF intégré, l'installation d'extraction de sang communiquant avec une étiquette RF à proximité de l'interrogateur RF, l'étiquette RF étant montée sur un récipient de stockage de sang adapté pour être utilisé avec l'installation d'extraction du sang.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562190230P | 2015-07-08 | 2015-07-08 | |
| US62/190,230 | 2015-07-08 | ||
| US201662290585P | 2016-02-03 | 2016-02-03 | |
| US62/290,585 | 2016-02-03 | ||
| PCT/US2016/041477 WO2017008000A1 (fr) | 2015-07-08 | 2016-07-08 | Procédés et systèmes pour communications rf dans des procédures d'extraction de sang |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2990289A1 true CA2990289A1 (fr) | 2017-01-12 |
Family
ID=57685877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2990289A Abandoned CA2990289A1 (fr) | 2015-07-08 | 2016-07-08 | Procedes et systemes pour communications rf dans des procedures d'extraction de sang |
Country Status (2)
| Country | Link |
|---|---|
| CA (1) | CA2990289A1 (fr) |
| WO (1) | WO2017008000A1 (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9418263B2 (en) | 2005-12-09 | 2016-08-16 | Tego, Inc. | Operating systems for an RFID tag |
| US9361568B2 (en) | 2005-12-09 | 2016-06-07 | Tego, Inc. | Radio frequency identification tag with hardened memory system |
| US9542577B2 (en) | 2005-12-09 | 2017-01-10 | Tego, Inc. | Information RFID tagging facilities |
| US9953193B2 (en) | 2014-09-30 | 2018-04-24 | Tego, Inc. | Operating systems for an RFID tag |
| CN109557808A (zh) * | 2018-10-30 | 2019-04-02 | 成都飞机工业（集团）有限责任公司 | 一种冗余计算机通道间互监控方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6861954B2 (en) * | 2001-03-30 | 2005-03-01 | Bruce H. Levin | Tracking medical products with integrated circuits |
| WO2010056287A1 (fr) * | 2008-10-30 | 2010-05-20 | Tagent Corporation | Suivi rfid de prélèvements d’échantillons de patients |
| WO2011157750A2 (fr) * | 2010-06-18 | 2011-12-22 | Cardlab Aps | Ensemble informatique comprenant un ordinateur actionnable uniquement lors de la réception d'un signal en provenance d'une unité portable actionnable |
| DK2716214T3 (en) * | 2011-05-18 | 2016-01-25 | Techno Medica Co Ltd | AUTOMATIC BLOOD TEST PREPARATION SYSTEM. |
-
2016
- 2016-07-08 CA CA2990289A patent/CA2990289A1/fr not_active Abandoned
- 2016-07-08 WO PCT/US2016/041477 patent/WO2017008000A1/fr active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017008000A1 (fr) | 2017-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10891449B2 (en) | Self-monitoring wireless computing device | |
| US9858452B2 (en) | Information RFID tagging facilities | |
| US9710682B2 (en) | Operating systems for an RFID tag | |
| US10430702B2 (en) | RF tag network connectivity through gateway facility | |
| US20180277241A1 (en) | Methods and systems for rf communications in fluid process procedures | |
| US9471821B2 (en) | External access to memory on an RFID tag | |
| US9405950B2 (en) | External access to memory on an RFID tag | |
| US9430732B2 (en) | Three-dimension RFID tag with opening through structure | |
| EP3201840A1 (fr) | Systèmes et procédés de gestion d'informations rfid | |
| EP2776982A1 (fr) | Installation de gestion de pilotage d'identité radiofréquence | |
| WO2015172053A1 (fr) | Étiquette d'identification par radiofréquence (rfid) souple destinée à être montée sur une surface métallique | |
| EP3245617A1 (fr) | Procédés et systèmes pour équipements de mémoire sur une étiquette rfid | |
| CA2990289A1 (fr) | Procedes et systemes pour communications rf dans des procedures d'extraction de sang |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |
Effective date: 20220929 |
|
| FZDE | Discontinued |
Effective date: 20220929 |